Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
ARDELYX, INC. (ARDX)
Sector: Healthcare; Industry: Biotechnology

Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-11-22 Rosenbaum David P. Chief Development Officer Sell 1,948 $1.95 $3,797 No
2022-11-22 GRAMMER ELIZABETH A nan Sell 1,242 $1.95 $2,421 No
2022-11-22 Rodriguez Susan Chief Commercial Officer Sell 3,456 $1.95 $6,736 No
2022-11-22 RAAB MICHAEL President & CEO Sell 6,219 $1.95 $12,120 No
2022-11-22 Renz Justin A Chief Financial Officer Sell 1,504 $1.95 $2,931 No
2022-11-22 Williams Laura A Chief Medical Officer Sell 1,241 $1.95 $2,419 No
2022-11-22 Blanks Robert nan Sell 1,464 $1.95 $2,853 No
2022-11-17 MOTT DAVID M Director Buy 567,000 $1.76 $1,000,642 No
2022-10-05 Blanks Robert nan Sell 100,000 $1.50 $150,000 No
2022-08-31 Felsch Robert Ora nan Buy 3,000 $0.62 $1,856 No
2022-08-31 Williams Laura A Chief Medical Officer Buy 3,000 $0.62 $1,856 No
2022-08-31 RAAB MICHAEL President & CEO Buy 3,000 $0.62 $1,856 No
2022-08-31 GRAMMER ELIZABETH A nan Buy 3,000 $0.62 $1,856 No
2022-08-26 Blanks Robert nan Sell 21,842 $1.04 $22,713 No
2022-08-22 Rodriguez Susan Chief Commercial Officer Sell 3,420 $0.98 $3,364 No
2022-08-22 Rosenbaum David P. Chief Development Officer Sell 1,955 $0.98 $1,923 No
2022-08-22 Blanks Robert nan Sell 1,458 $0.98 $1,434 No
2022-08-22 RAAB MICHAEL President & CEO Sell 6,146 $0.98 $6,045 No
2022-08-22 GRAMMER ELIZABETH A nan Sell 1,236 $0.98 $1,216 No
2022-08-22 Williams Laura A Chief Medical Officer Sell 1,276 $0.98 $1,255 No
2022-07-26 Blanks Robert nan Sell 5,188 $0.67 $3,476 No
2022-06-06 Blanks Robert nan Sell 73,312 $0.65 $47,696 No
2022-06-06 GRAMMER ELIZABETH A nan Sell 60,821 $0.65 $39,569 No
2022-06-06 Rosenbaum David P. Chief Development Officer Sell 61,640 $0.65 $40,102 No
2022-06-06 RAAB MICHAEL President & CEO Sell 103,624 $0.65 $67,416 No
2022-05-20 Rosenbaum David P. Chief Development Officer Sell 2,013 $0.67 $1,352 No
2022-05-20 Renz Justin A Chief Financial Officer Sell 1,528 $0.67 $1,026 No
2022-05-20 Rodriguez Susan Chief Commercial Officer Sell 3,425 $0.67 $2,300 No
2022-05-20 RAAB MICHAEL President & CEO Sell 6,124 $0.67 $4,112 No
2022-05-20 GRAMMER ELIZABETH A nan Sell 1,263 $0.67 $848 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.